Latest Australian Taxation News

Domain Holdings Australia Limited is set for acquisition by CoStar Group at $4.43 per share, a premium supported by the Domain Board, Independent Expert, and controlling shareholder Nine. The scheme awaits shareholder and court approval, with a meeting scheduled for August.

GTN Limited is set to seek shareholder approval for a substantial $44 million capital return, aiming to reward investors without compromising its dividend policy.

State Street Global Advisors has announced a substantial cash distribution for the SPDR S&P/ASX 200 ESG ETF, reflecting the fund’s income and tax attributes for the year ending June 2025.

State Street Global Advisors has announced a 21.5897 cents per unit cash distribution for the SPDR S&P/ASX Small Ordinaries ETF for the period ending June 30, 2025, alongside franking and foreign tax credits.

State Street Global Advisors has announced a 31.56 cents per unit cash distribution for the SPDR S&P/ASX 200 Listed Property ETF for the period ending June 30, 2025, including franking and foreign tax credits.

State Street Global Advisors announces a substantial cash distribution for the SPDR S&P World ex Australia Carbon Aware ETF, highlighting a blend of income and tax credits for investors.

Indiana Resources Limited has announced a proposed capital return of five cents per share, backed by a draft ATO ruling confirming its tax-efficient status. The company plans a $32.2 million cash distribution, maintaining a strong balance sheet post-payment.

The Australian Taxation Office has issued a binding ruling clarifying the tax treatment for De Grey Mining shareholders following Northern Star Resources’ acquisition. The ruling confirms capital gains tax deferral options for eligible investors.

Kip McGrath Education Centres has appointed Melinda Smith as CEO and Managing Director, signaling a new leadership era ahead of its 50th anniversary. Smith’s extensive experience in education and government sectors positions her to lead the company’s growth ambitions from the second half of 2025.

The Reject Shop has announced a fully franked special dividend of $0.77 per share as part of its acquisition by Dollarama, boosting the total transaction consideration to $6.68 per share.

Chimeric Therapeutics has secured a $2.5 million advance against its FY25 R&D tax incentive, bolstering funding for its clinical trial pipeline and operational needs. This move complements recent capital raises and underscores the company’s strategic financial management amid its oncology-focused cell therapy development.

Algorae Pharmaceuticals has secured a significant A$318,771 R&D tax incentive rebate from the Australian Taxation Office, providing a non-dilutive cash injection to advance its AI-driven drug discovery programs.